Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer. Ratajska, M., Koczkowska, M., Żuk, M., Gorczyński, A., Kuźniacka, A., Stukan, M., Biernat, W., Limon, J., & Wasąg, B. Oncotarget, 8(60):101325–101332, September, 2017.
Paper doi bibtex 2 downloads @article{ratajska_detection_2017,
title = {Detection of {BRCA1}/2 mutations in circulating tumor {DNA} from patients with ovarian cancer},
volume = {8},
issn = {1949-2553},
url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731877/},
doi = {10.18632/oncotarget.20722},
number = {60},
urldate = {2020-02-11},
journal = {Oncotarget},
author = {Ratajska, Magdalena and Koczkowska, Magdalena and Żuk, Monika and Gorczyński, Adam and Kuźniacka, Alina and Stukan, Maciej and Biernat, Wojciech and Limon, Janusz and Wasąg, Bartosz},
month = sep,
year = {2017},
pmid = {29254167},
pmcid = {PMC5731877},
keywords = {Alamut, BRCA1, BRCA1/2, BRCA2, Blood, Clinical Trials, Clinical study, Genomics, Hereditary Disorders, Liquid Biopsy, Ovarian Cancer, PARP1 inhibitors, SOPHiA DDM, ctDNA},
pages = {101325--101332},
}
Downloads: 2
{"_id":"NArs7XMNvJvMbReGa","bibbaseid":"ratajska-koczkowska-uk-gorczyski-kuniacka-stukan-biernat-limon-etal-detectionofbrca12mutationsincirculatingtumordnafrompatientswithovariancancer-2017","author_short":["Ratajska, M.","Koczkowska, M.","Żuk, M.","Gorczyński, A.","Kuźniacka, A.","Stukan, M.","Biernat, W.","Limon, J.","Wasąg, B."],"bibdata":{"bibtype":"article","type":"article","title":"Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer","volume":"8","issn":"1949-2553","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731877/","doi":"10.18632/oncotarget.20722","number":"60","urldate":"2020-02-11","journal":"Oncotarget","author":[{"propositions":[],"lastnames":["Ratajska"],"firstnames":["Magdalena"],"suffixes":[]},{"propositions":[],"lastnames":["Koczkowska"],"firstnames":["Magdalena"],"suffixes":[]},{"propositions":[],"lastnames":["Żuk"],"firstnames":["Monika"],"suffixes":[]},{"propositions":[],"lastnames":["Gorczyński"],"firstnames":["Adam"],"suffixes":[]},{"propositions":[],"lastnames":["Kuźniacka"],"firstnames":["Alina"],"suffixes":[]},{"propositions":[],"lastnames":["Stukan"],"firstnames":["Maciej"],"suffixes":[]},{"propositions":[],"lastnames":["Biernat"],"firstnames":["Wojciech"],"suffixes":[]},{"propositions":[],"lastnames":["Limon"],"firstnames":["Janusz"],"suffixes":[]},{"propositions":[],"lastnames":["Wasąg"],"firstnames":["Bartosz"],"suffixes":[]}],"month":"September","year":"2017","pmid":"29254167","pmcid":"PMC5731877","keywords":"Alamut, BRCA1, BRCA1/2, BRCA2, Blood, Clinical Trials, Clinical study, Genomics, Hereditary Disorders, Liquid Biopsy, Ovarian Cancer, PARP1 inhibitors, SOPHiA DDM, ctDNA","pages":"101325–101332","bibtex":"@article{ratajska_detection_2017,\n\ttitle = {Detection of {BRCA1}/2 mutations in circulating tumor {DNA} from patients with ovarian cancer},\n\tvolume = {8},\n\tissn = {1949-2553},\n\turl = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731877/},\n\tdoi = {10.18632/oncotarget.20722},\n\tnumber = {60},\n\turldate = {2020-02-11},\n\tjournal = {Oncotarget},\n\tauthor = {Ratajska, Magdalena and Koczkowska, Magdalena and Żuk, Monika and Gorczyński, Adam and Kuźniacka, Alina and Stukan, Maciej and Biernat, Wojciech and Limon, Janusz and Wasąg, Bartosz},\n\tmonth = sep,\n\tyear = {2017},\n\tpmid = {29254167},\n\tpmcid = {PMC5731877},\n\tkeywords = {Alamut, BRCA1, BRCA1/2, BRCA2, Blood, Clinical Trials, Clinical study, Genomics, Hereditary Disorders, Liquid Biopsy, Ovarian Cancer, PARP1 inhibitors, SOPHiA DDM, ctDNA},\n\tpages = {101325--101332},\n}\n\n\n\n","author_short":["Ratajska, M.","Koczkowska, M.","Żuk, M.","Gorczyński, A.","Kuźniacka, A.","Stukan, M.","Biernat, W.","Limon, J.","Wasąg, B."],"key":"ratajska_detection_2017","id":"ratajska_detection_2017","bibbaseid":"ratajska-koczkowska-uk-gorczyski-kuniacka-stukan-biernat-limon-etal-detectionofbrca12mutationsincirculatingtumordnafrompatientswithovariancancer-2017","role":"author","urls":{"Paper":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731877/"},"keyword":["Alamut","BRCA1","BRCA1/2","BRCA2","Blood","Clinical Trials","Clinical study","Genomics","Hereditary Disorders","Liquid Biopsy","Ovarian Cancer","PARP1 inhibitors","SOPHiA DDM","ctDNA"],"metadata":{"authorlinks":{}},"downloads":2},"bibtype":"article","biburl":"https://bibbase.org/zotero/SOPHiAGENETICS","dataSources":["Pcpsxmwz8uxXtL843","vPYMrJTaJTbhFPPb4"],"keywords":["alamut","brca1","brca1/2","brca2","blood","clinical trials","clinical study","genomics","hereditary disorders","liquid biopsy","ovarian cancer","parp1 inhibitors","sophia ddm","ctdna"],"search_terms":["detection","brca1","mutations","circulating","tumor","dna","patients","ovarian","cancer","ratajska","koczkowska","żuk","gorczyński","kuźniacka","stukan","biernat","limon","wasąg"],"title":"Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer","year":2017,"downloads":2}